Mcal Therapeutics
San Francisco, US · Founded 2020 · Delaware corporation · 1 known investors
Biotechnology company developing treatments for ophthalmic diseases, focusing on dry eye through a topical ophthalmology platform.
Founders & leadership
Mcal Therapeutics was founded in 2020 by Tom Gadek.
TG
Tom GadekinFounderTom Gadek founded MCAL Therapeutics and previously founded SARcode Biosciences, where he served as CEO until its acquisition by Shire in 2013; he earned a Ph.D. in synthetic organic chemistry from UC Berkeley and has over 70 patent inventions and peer-reviewed publications in pharmaceutical drug discovery and development.
CJ
Christopher J. MurphyNamed on SEC filing
CO
Charles O'NeillNamed on SEC filing
TS
Tanya ShnaydmanNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$6.3M disclosed across 2 rounds · 2020–2024
▶$5.9MraisedMar 2024 · 29 investors · OtherRule 506(b)
▶$5.9MraisedMar 2024 · 29 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- Tom GadekExecutive Officer, Director
- Charles O'NeillDirector
- Chris J. MurphyDirector
- Dan AlbertDirector
- Tom MatherDirector
- Offering amount
- $5.9M
- Amount sold
- $5.9M
- First sale
- Mar 2024
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
▶$450KraisedJun 2020 · 5 investors · PharmaceuticalsRule 506(b)
▶$450KraisedJun 2020 · 5 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Thomas GadekExecutive Officer, Director
- Christopher J. MurphyDirector
- Charles O'NeillExecutive Officer, Director
- Tanya ShnaydmanExecutive Officer
- Offering amount
- $450K
- Amount sold
- $450K
- First sale
- May 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- What does Mcal Therapeutics do?
- Biotechnology company developing treatments for ophthalmic diseases, focusing on dry eye through a topical ophthalmology platform.
- Who founded Mcal Therapeutics?
- Mcal Therapeutics was founded by Tom Gadek in 2020.
- Who are Mcal Therapeutics's investors?
- Mcal Therapeutics's investors include OphthaFund.
- How much funding has Mcal Therapeutics raised?
- Mcal Therapeutics has disclosed $6.3M raised across 2 rounds.
- Where is Mcal Therapeutics headquartered?
- Mcal Therapeutics is headquartered in San Francisco, US.